221 related articles for article (PubMed ID: 38334649)
1. A Cataract-Causing Mutation in the TRPM3 Cation Channel Disrupts Calcium Dynamics in the Lens.
Zhou Y; Bennett TM; Ruzycki PA; Guo Z; Cao YQ; Shahidullah M; Delamere NA; Shiels A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334649
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses.
Zhou Y; Bennett TM; Shiels A
FASEB J; 2021 Feb; 35(2):e21288. PubMed ID: 33484482
[TBL] [Abstract][Full Text] [Related]
3. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
Zhao S; Yudin Y; Rohacs T
Elife; 2020 Apr; 9():. PubMed ID: 32343227
[TBL] [Abstract][Full Text] [Related]
4. TRPM3_miR-204: a complex locus for eye development and disease.
Shiels A
Hum Genomics; 2020 Feb; 14(1):7. PubMed ID: 32070426
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the melastatin-related cation channel, TRPM3, underlies inherited cataract and glaucoma.
Bennett TM; Mackay DS; Siegfried CJ; Shiels A
PLoS One; 2014; 9(8):e104000. PubMed ID: 25090642
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential melastatin-3 (TRPM3)-induced activation of AP-1 requires Ca2+ ions and the transcription factors c-Jun, ATF2, and ternary complex factor.
Lesch A; Hui X; Lipp P; Thiel G
Mol Pharmacol; 2015 Apr; 87(4):617-28. PubMed ID: 25576487
[TBL] [Abstract][Full Text] [Related]
7. Control of Insulin Release by Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels.
Becker A; Mannebach S; Mathar I; Weissgerber P; Freichel M; Loodin AP; Fecher-Trost C; Belkacemi A; Beck A; Philipp SE
Cell Physiol Biochem; 2020 Nov; 54(6):1115-1131. PubMed ID: 33166100
[TBL] [Abstract][Full Text] [Related]
8. TRPM3 is a nociceptor channel involved in the detection of noxious heat.
Vriens J; Owsianik G; Hofmann T; Philipp SE; Stab J; Chen X; Benoit M; Xue F; Janssens A; Kerselaers S; Oberwinkler J; Vennekens R; Gudermann T; Nilius B; Voets T
Neuron; 2011 May; 70(3):482-94. PubMed ID: 21555074
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Signal-Regulated Protein Kinase, c-Jun N-Terminal Protein Kinase, and Calcineurin Regulate Transient Receptor Potential M3 (TRPM3) Induced Activation of AP-1.
Lesch A; Rössler OG; Thiel G
J Cell Biochem; 2017 Aug; 118(8):2409-2419. PubMed ID: 28112420
[TBL] [Abstract][Full Text] [Related]
10. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
11. Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1.
Becker A; Götz C; Montenarh M; Philipp SE
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884938
[TBL] [Abstract][Full Text] [Related]
12. Ca
Przibilla J; Dembla S; Rizun O; Lis A; Jung M; Oberwinkler J; Beck A; Philipp SE
Cell Calcium; 2018 Jul; 73():40-52. PubMed ID: 29880196
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction via TRPM3 channels in pancreatic β-cells.
Thiel G; Müller I; Rössler OG
J Mol Endocrinol; 2013 Jun; 50(3):R75-83. PubMed ID: 23511953
[TBL] [Abstract][Full Text] [Related]
15. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
[TBL] [
